about
8-Oxoguanine incorporation into DNA repeats in vitro and mismatch recognition by MutSDNA Polymerases λ and β: The Double-Edged Swords of DNA RepairStudies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors.Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.Impact of ribonucleotide incorporation by DNA polymerases β and λ on oxidative base excision repair.How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?Living on the Edge: DNA Polymerase Lambda between Genome Stability and Mutagenesis.Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors.Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.Next generation of antiretroviral agents targeting the RNA binding site of the HIV-1 cellular cofactor DDX3: an innovative therapeutic approach.Identification of broad-spectrum dengue/Zika virus replication inhibitors by functionalization of quinoline and 2,6-diaminopurine scaffolds.p15PAF binding to PCNA modulates the DNA sliding surfaceInhibitors of human immunodeficiency virus-1 replication targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicaseMolecular docking, design, synthesis and biological evaluation of novel 2,3-aryl-thiazolidin-4-ones as potent NNRTIsEffect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3 H)-onesMultitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus InfectionFrom the magic bullet to the magic target: exploiting the diverse roles of DDX3X in viral infections and tumorigenesisIdentification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell linesIdentification of a novel antiviral micro-RNA targeting the NS1 protein of the H1N1 pandemic human influenza virus and a corresponding viral escape mutationDNA replication: a complex matter
P50
Q24811035-A9CBEC91-0FD2-425A-B40E-4738A3425FB1Q28078519-658200C1-1E98-466F-BC2A-0DCEBD575C32Q35617834-B068C1E1-0532-4977-ABB5-14175A7AF439Q36904981-5A957B61-0C18-46C1-AC8F-3A821310913EQ38707199-488478AC-5FFE-47A6-AF9D-C5CA4E643FF0Q39265247-9D99128A-EC5E-4808-AAA2-D361612555D7Q40070438-49633876-3DC6-4C8A-B958-BADB4FCEA1AFQ40132127-9EB72FFB-CDBF-4268-B39F-4AC8F9763ED8Q40154491-99AB4A1C-BAFC-4B89-A6FF-A20AF84610F7Q45911766-2C89B3DB-FAF5-479E-A2FD-7BEC346C74C2Q54217487-137670FF-1CC0-46F8-B8B3-36B95BF712EBQ58794746-3D328F4A-2B77-443F-BC86-F05CA9D7FE79Q59254100-6E809254-82C6-4D06-8ACB-8E2F7549D556Q90203587-4FC3B9E6-C562-45C0-A462-C23EDFE4469DQ90331294-747B09EC-5842-4385-BAAF-DD2D0461EF1BQ91293661-5AF03DB8-3933-4DC8-8267-5E8D93C6B373Q91350840-C5AF8388-CBE8-4EA0-986F-8197A26F5135Q91995598-E2A0A41E-A00F-471E-89A6-526BA8E123AEQ92541753-EF71E342-724C-4BFA-AFFA-F954B761BD78Q93013161-7CFED551-07D2-4440-BCFA-2D79EA2B7491Q93712323-101F8063-99C8-435F-8FED-338F0791A6F5
P50
description
investigador
@es
researcher
@en
name
Giovanni Maga
@en
type
label
Giovanni Maga
@en
prefLabel
Giovanni Maga
@en
P31
P496
0000-0001-8092-1552